Pharyngitis Treatment Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends|Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc

 

The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to adoption of rapid point-of-care tests, demand for personalized medicine, prevalence of antibiotic resistance, rising importance of hand hygiene. Major trends in the forecast period include advancements in research and development of pharyngitis therapies, digital health technologies, telehealth integration, .

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report

Segmentation & Regional Insights
The pharyngitis treatment market covered in this report is segmented –

1) By Drug Class: Beta Lactams; Macrolides; Cephalosporins; Fluoroquinolones; Tetracycline; Other Drug Classes
2) By Source of Infection: Viral; Bacterial
3) By Modes Of Delivery: Oral; Intravenous; Intramuscular; Other Modes Of Delivery
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users

North America was the largest region in the pharyngitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp

Major Driver Impacting Market Growth
The rising transmission of strep throat is expected to propel the growth of the pharyngitis treatment market going forward. Strep throat is a contagious bacterial infection that primarily affects the throat and tonsils. Prompt and effective treatment of strep throat with antibiotics helps alleviate symptoms, prevent complications and reduce the risk of spreading the infection to others. For instance, in June 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, every year, approximately 14,000 to 25,000 cases of invasive group A strep disease occur in the United States. Additionally, strep diseases lead to 5.2 million outpatient visits and 2.8 million antibiotic prescriptions annually. Therefore, the rising transmission of strep throat drives the pharyngitis treatment market.

Key Industry Players
Major players in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

The pharyngitis treatment market report table of contents includes:

1. Executive Summary
2. Pharyngitis Treatment Market Characteristics
3. Pharyngitis Treatment Market Trends And Strategies
4. Pharyngitis Treatment Market – Macro Economic Scenario
5. Global Pharyngitis Treatment Market Size and Growth

.

.

.

32. Global Pharyngitis Treatment Market Competitive Benchmarking
33. Global Pharyngitis Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In Pharyngitis Treatment Market
35. Pharyngitis Treatment Market Future Outlook and Potential Analysis
36. Appendix

 

Top Major Players :

• Pfizer Inc
• GlaxoSmithKline PLC
• Genentech Inc
• Pliva Hrvatska D.o.o.
• Viatris Inc

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model